P3882Safety of continuous use of Apixaban, Rivaroxaban and Dabigatran in patients undergoing cardiac implantable electronic device implantation in a real-world cohort | Zendy

AI Assistant Blog Pricing

P3882Safety of continuous use of Apixaban, Rivaroxaban and Dabigatran in patients undergoing cardiac implantable electronic device implantation in a real-world cohort

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.